| 000 | 01717 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515015736.0 | ||
| 264 | 0 | _c20061024 | |
| 008 | 200610s 0 0 eng d | ||
| 022 | _a0012-186X | ||
| 024 | 7 |
_a10.1007/s00125-006-0168-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTooke, J E | |
| 245 | 0 | 0 |
_aThe insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin. _h[electronic resource] |
| 260 |
_bDiabetologia _cMay 2006 |
||
| 300 |
_a1064-70 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrocirculation _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPioglitazone |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aThiazolidinediones _xtherapeutic use |
| 700 | 1 | _aElston, L M | |
| 700 | 1 | _aGooding, K M | |
| 700 | 1 | _aBall, C I | |
| 700 | 1 | _aMawson, D M | |
| 700 | 1 | _aPiper, J | |
| 700 | 1 | _aSriraman, R | |
| 700 | 1 | _aUrquhart, R | |
| 700 | 1 | _aShore, A C | |
| 773 | 0 |
_tDiabetologia _gvol. 49 _gno. 5 _gp. 1064-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-006-0168-9 _zAvailable from publisher's website |
| 999 |
_c16119185 _d16119185 |
||